Search results
Blocking gene may halt growth of breast cancer cells
Medical Xpress· 14 hours ago"Combining an anti-estrogen therapy with a drug that inhibits PRMT5 could eventually offer a new way to treat patients resistant to CDK4/6 inhibitors, who often have few options ...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Morningstar· 1 day ago-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion ...
Blocking gene may halt growth of breast cancer cells
Newswise· 1 day agoShutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a stand
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment...
Morningstar· 4 days agoLexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company, today announced an in-license agreement with Cornell University to expedite development of the investigational ...
Valley Stream boy, 8, is first in New York State to receive new therapy for blood disorder
Newsday· 7 days agoYusef Saeed, of Valley Stream, received on Jan. 9 an infusion of Zynteglo gene therapy at Cohen...
Parkinson's Disease Risk Variants Found in Pesticide-Exposed Patients
GenomeWeb News· 13 hours agoA University of California, Los Angeles research team has tracked down Parkinson's disease-associated variants in pesticide-exposed individuals with the neurodegenerative disease, pointing to ...
Olivia Munn Talks About Breast Cancer Treatment Leading to Menopause
Healthline· 7 days agoActress Olivia Munn revealed that she had been diagnosed with bilateral breast cancer last year. In...
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
Zacks· 1 day agoRevenues in the last quarter were impacted by a $10.3 million recognition adjustment owing to Regeneron Pharmaceuticals (REGN Quick QuoteREGN - Free Report) extending the technology collaboration ...
Earnings call: BioMarin reports solid Q1 growth, plans strategic updates By Investing.com
Investing.com· 14 hours agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced strong first-quarter financials and strategic...
3 Contrarian Investments to Make Now for Massive Upside Potential
InvestorPlace· 13 hours agoThe phenomenon has been exacerbated by overdone fears about elevated interest rates. Short sellers...